Evaluation of the Efficiency of Vasonate in Patients With Comorbid Pathology: Hypertensive Disease and Liver Steatosis

Likarska sprava
doi 10.31640/jvd.1-2.2018(16)
Full Text
Abstract

Available in full text

Date
Authors
Publisher

LLC Information and Research Center Likarska Sprava

Related search

Parameters of Carbohydrate Metabolism and Expression of Liver Steatosis in Patients With Nonalcoholic Fatty Liver Disease and Hypertensive Depending on Lipid Parameters

Ukraïnsʹkij žurnal medicini, bìologìï ta sportu
2019English

Ischemic Stroke in the Patients With Comorbid Pathology

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2018English

Features of Patients With Comorbid Pathology Treatment in Internal Medicine

Zaporozhye Medical Journal
2015English

Reproducibility of Transient Elastography in the Evaluation of Liver Fibrosis in Patients With Chronic Liver Disease

Gut
Gastroenterology
2007English

Pathology of Liver Cirrhosis in Patients With Cystic Fibrosis of the Pancreas

JAMA - Journal of the American Medical Association
Medicine
1963English

Adherence to Treatment and Evaluation of Disease and Therapy Knowledge in Lebanese Hypertensive Patients

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2017English

Relationship of Steatosis Grade and Zonal Location to Histological Features of Steatohepatitis in Adult Patients With Non-Alcoholic Fatty Liver Disease

Journal of Hepatology
Hepatology
2008English

Gender Features of Lipid Metabolism Disorders in Elderly Patients With Subclinical Hypothyroidism on the Background of Comorbid Pathology

Bukovinian Medical Herald
2019English

Serous Cytokines and Marker of Endothelium Damage Activity in Patients With Liver Steatosis, Fibrosis and Cirrhosis

The Journal of scientific articles "Health and Education millennium"
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy